Table of Contents
Definition of Acute Cystitis
Acute cystitis is defined as an acute inflammation of the urinary bladder. It is a type of urinary tract infection that is common among women.
Acute uncomplicated cystitis occurs in persons with a normal, unobstructed genitourinary tract and without any history of instrumentation. It commonly occurs in young sexually active women.
Epidemiology of Acute Cystitis
Approximately 7 million people present to outpatient clinics due to acute cystitis. This is associated with a tremendous cost burden of up to $1.6 billion on the health care system. Urinary tract infections (UTIs), including acute cystitis, are common among sexually active women. In the United States, one out of three women from 20–40 years of age has a UTI.
The risk factors include recent use of antibiotics, sexual intercourse, abnormal urinary tract anatomy, urethral instrumentation, and urinary tract obstruction by stones or other disease processes.
The most common identified causative organism is Escherichia coli. Staphylococcus saprophyticus, Klebsiella species, and Proteus are responsible for most of the remaining cases.
Most common etiology: E. coli
Only a few serogroups cause most of the infections, e.g., ‘uropathogenic E. coli.’
Pathophysiology of Acute Cystitis
The urinary tract system should be sterile. E. coli normally inhabits the periurethral vaginal opening and can ascend to the bladder and invade the mucosal lining of the bladder. The presence of pathologic E. coli would result in the inflammation of the bladder (cystitis).
Adhesins that are expressed on the bacterial surfaces play an important role in the adhesion of bacteria to the urinary epithelium.
Host resistance also plays a role in the pathophysiology of UTIs.
Sexual intercourse, urinary tract obstruction, and instrumentation by urethral catheterization put the patient at risk of developing UTIs and cystitis.
Women have a higher incidence of acute cystitis because:
- Shorter urethra that is closer to the anus and has exposure to colon flora
- Causative organisms colonize the vaginal introitus and periurethral area
- Massage of the urethra in women during sexual intercourse forces bacteria into the bladder
- Motile bacteria can ascend the urinary tract against the urinary stream
Lactobacilli are nonpathogenic bacteria that colonize the vagina in healthy premenopausal women. Recent use of antibiotics for any indication can eradicate these bacteria, allowing room for uropathogenic bacteria to grow and colonize the urogenital tracts.
Clinical Presentation of Acute Cystitis
Patients with acute cystitis present with irritative lower urinary tract symptoms such as burning micturition (dysuria), urinary urgency, and frequency. These patients may also present with fever, lower abdominal or flank pain, and hematuria. These patients are often not toxic or severely ill. If the patient has a fever, chills, and severe costovertebral angle tenderness, the possibility of acute pyelonephritis should be excluded.
Urinary frequency is different from polyuria. In urinary frequency, the patient has to urinate multiple times, but the total volume of urinary output is not increased. In polyuria, the total volume of urinary output is increased, such as in patients with diabetes insipidus, diabetes mellitus, or nephrotic syndrome.
Suprapubic tenderness is common in patients with acute cystitis. Because of the overlap of the symptoms with pelvic inflammatory disease (PID), a pelvic examination is indicated. In contrast to PID, patients with acute cystitis should not have cervical tenderness or vaginitis.
Diagnostic Workup of Acute Cystitis
Urine analysis is the first step in diagnosis. The presence of > 10 WBCs per mL of urine or pus (pyuria) is indicative of a UTI. Nitrate tests detect the presence of uropathogens by detecting the byproducts of the bacterial nitrate reductase enzymes. The specificity of this test can be as high as 100%.
However, the gold standard for the diagnosis of UTIs remains urine culture. Patients with > 100,000 colony-forming units per mL of urine are diagnosed with acute cystitis.
Complete blood counts (CBCs) may show elevated WBCs with neutrophilia.
Presumptive diagnosis in the presence of pyuria:
- Greater than 10 WBC/µL of midstream urine in a counting chamber
- Greater than 5–10 WBC/high-power microscopic field in a centrifuged urine sample
- Dipstick leukocyte esterase test:
- Sensitivity: 75–96%
- Specificity: 94–98%
- Microscopic hematuria
- Urine culture: > 105 bacteria/mL (most patients)
- < 105/mL in some symptomatic patients
- Gram stain of uncentrifuged, mid-stream urine:
- Presence of 1 organism/microscopic field ≈ 105 organisms/mL
Treatment of Acute Cystitis
Antibiotics are the mainstay of the treatment of acute cystitis but recent data shows that symptoms can resolve without any specific treatment. Therefore, some experts recommend allowing for a 48-hour delay of antibiotic treatment if the patient agrees to see if their symptoms would improve on their own.
If antibiotics are used, the first-line therapy is usually trimethoprim-sulfamethoxazole. Ciprofloxacin should not be used in uncomplicated cases of acute cystitis to lower the risk of developing resistant organisms. Once antibiotic therapy is started, symptoms usually take 6 days to resolve.
Patients who cannot receive trimethoprim-sulfamethoxazole for some reason, such as allergic reactions to sulfonamides, can receive fosfomycin or ciprofloxacin.
Patients with complicated acute cystitis due to a history of recurrent UTIs, being pregnant, or having diabetes mellitus should receive ciprofloxacin as first-line therapy.
Patients with complicated acute cystitis and who cannot tolerate oral antibiotics should receive intravenous ciprofloxacin or ampicillin plus gentamicin.
Patients with asymptomatic bacteriuria who are not pregnant should not receive any specific treatment. On the other hand, pregnant women with asymptomatic bacteriuria might benefit from antibiotic therapy.
Antibacterial agent choices
Antibacterials with good activity against an offending pathogen and that have the least effect on vaginal and intestinal flora include the following:
- Nitrofurantoin (5 days), fosfomycin (1 day), trimethoprim-sulfamethoxazole (TMP/SMX) (3 days), and pivmecillinam (3–7 days)
- Fluoroquinolones (3 days)—held in reserve
Management of recurrent cystitis
- TMP/SMX (single strength), nitrofurantoin or fluoroquinolone after intercourse
- Long-term prophylaxis: nightly nitrofurantoin 50 mg, TMP/SMX (half tablet) or a fluoroquinolone